Main Session
Sep
29
SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy
312 - Genomic Stratification of Benefit from Short-Term Androgen Deprivation with Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer: An Ancillary Study of NRG/RTOG 0815
Presenter(s)
Angela Jia, MD, PhD - University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH